Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol lead-in before hydroquinone for facial melasma
RBR-4mzcwpwPhase 3Not yet recruiting
- Sponsor
- Universidade Estadual Paulista
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in melasma comparing Clobetasol lead-in followed by hydroquinone with Hydroquinone alone (2 arms). Planned start Jan 2023; status: not yet recruiting.
02
Drugs
clobetasolhydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on RBR-4mzcwpw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4mzcwpw.